HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
PDF Library
RSS Feeds
Subscribe
Advertising
Partnered Content
Report Store
UsernamePublicRestriction
Tags:
United States US States Advertising, Marketing & Sales

Hemp Product Market Future Backed By McConnell, Fate Depends On Farm Bill

This article was originally published in The Rose Sheet

  • News

Executive Summary

The surprising support of Senate majority leader Mitch McConnell is integral to the success of a provision in legislation to reauthorize USDA programs that would clarify hemp's removal from the federal list of controlled substances and ease limits on its production in the US. Meanwhile, Charlotte's Web Holdings' recent $100m IPO is a strong sign of investors' confidence in the future market for hemp products.

Table

View full table

Advertisement

Related Content

HBW Insight
FDA To Consider Regulatory Shift Making Cannabis Ingredients Officially Eligible For Use In Dietary Supplements
HBW Insight
Elections Reshape Congress But Not Supplement Industry Regulatory Outlook
HBW Insight
Farm Bill Would Boost USDA Organic Program Funding, Supply Chain Safety
HBW Insight
House And Senate Farm Bills Dilemma: Each Includes One, But Not Both Of Supplement Industry's SNAP, Hemp Goals
HBW Insight
CBD Drug Approval Not A Sign FDA Will Allow Its Use In Supplements
HBW Insight
Making Nutritionals Eligible For Health Savings Accounts Whets Congress' Appetite

Topics

Advertisement
Tags:
United States US States Advertising, Marketing & Sales
UsernamePublicRestriction

Register

RS121826

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By